Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are on the front lines in the battle against unknown diseases with the JLABS/BARDA Blue Knight program. Seth Salpeter, Co-Founder and CEO of Immunyx Pharma guests on BioTalk with Rich Bendis
Rip Ballou, GSK Global Vaccines (EP.14)
Matt Brady, Scheer Partners (EP.13)
Margaret Anderson, Deloitte Consulting (EP.12)
BioHealth Capital Region Forum: Part 2 - Todd Haim, NIH and Matthew McMahon, NIH
BioHealth Capital Region Forum: Part 1 - Jim Jackson, Emergent BioSolutions and Jim Hughes, University of Maryland, Baltimore
Christy Wyskiel, Johns Hopkins University (EP.11)
Lily Qi, Office of Montgomery County Executive (EP.10)
David Petr, Montgomery County Economic Development Corporation (MCEDC) (EP.09)
Rachel King, GlycoMimetics, Inc. (GMI) (EP.08)
Dr. Jay Perman, University of Maryland, Baltimore (UMB) (EP.07)
George Davis, Maryland Technology Development Corporation (TEDCO) (EP.06)
Jonathan Cohen, 20/20 GeneSystems Inc. (EP.05)
Kurt Newman, M.D., Children’s National Health System (EP.04)
Tami Howie, Maryland Tech Council (EP.03)
Daniel Abdun-Nabi, Emergent BioSolutions (EP.02)
Douglas Liu, QIAGEN (EP.01)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money